ATE400287T1 - Niedrigdosierte lhrh antagonisten zur behandlung von neurodegenerativen krankheiten, insbesondere alzheimer krankheit - Google Patents

Niedrigdosierte lhrh antagonisten zur behandlung von neurodegenerativen krankheiten, insbesondere alzheimer krankheit

Info

Publication number
ATE400287T1
ATE400287T1 AT02735312T AT02735312T ATE400287T1 AT E400287 T1 ATE400287 T1 AT E400287T1 AT 02735312 T AT02735312 T AT 02735312T AT 02735312 T AT02735312 T AT 02735312T AT E400287 T1 ATE400287 T1 AT E400287T1
Authority
AT
Austria
Prior art keywords
disease
treatment
neurodegenerative diseases
low dose
lhrh antagonists
Prior art date
Application number
AT02735312T
Other languages
English (en)
Inventor
Juergen Engel
Rainer Voegeli
Original Assignee
Aeterna Zentaris Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aeterna Zentaris Gmbh filed Critical Aeterna Zentaris Gmbh
Application granted granted Critical
Publication of ATE400287T1 publication Critical patent/ATE400287T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
AT02735312T 2001-04-30 2002-04-27 Niedrigdosierte lhrh antagonisten zur behandlung von neurodegenerativen krankheiten, insbesondere alzheimer krankheit ATE400287T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US28743401P 2001-04-30 2001-04-30

Publications (1)

Publication Number Publication Date
ATE400287T1 true ATE400287T1 (de) 2008-07-15

Family

ID=23102886

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02735312T ATE400287T1 (de) 2001-04-30 2002-04-27 Niedrigdosierte lhrh antagonisten zur behandlung von neurodegenerativen krankheiten, insbesondere alzheimer krankheit

Country Status (28)

Country Link
US (1) US7288517B2 (de)
EP (1) EP1392348B1 (de)
JP (1) JP2004529207A (de)
KR (1) KR20040000446A (de)
CN (1) CN1317030C (de)
AT (1) ATE400287T1 (de)
AU (1) AU2002310788B2 (de)
BG (1) BG108339A (de)
BR (1) BR0209290A (de)
CA (1) CA2444876A1 (de)
CZ (1) CZ20033167A3 (de)
DE (1) DE60227507D1 (de)
DK (1) DK1392348T3 (de)
ES (1) ES2307760T3 (de)
HK (1) HK1072000A1 (de)
HU (1) HUP0400067A2 (de)
IL (1) IL156777A0 (de)
MX (1) MXPA03008666A (de)
NO (1) NO20034322L (de)
NZ (1) NZ544417A (de)
PL (1) PL362319A1 (de)
PT (1) PT1392348E (de)
RU (1) RU2319501C2 (de)
SI (1) SI1392348T1 (de)
SK (1) SK14512003A3 (de)
UA (1) UA80679C2 (de)
WO (1) WO2002102401A1 (de)
ZA (1) ZA200305326B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6828415B2 (en) * 1993-02-19 2004-12-07 Zentaris Gmbh Oligopeptide lyophilisate, their preparation and use
US20020077327A1 (en) * 1999-09-23 2002-06-20 Neurocrine Biosciences, Inc. Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
KR100748294B1 (ko) * 2000-07-05 2007-08-09 아스텔라스세이야쿠 가부시키가이샤 프로판-1,3-디온 유도체
DE10137174A1 (de) * 2001-07-31 2003-02-13 Zentaris Ag Verwendung von LHRH-Antagonisten in nichtkastrierenden Dosen zur Verbesserung der T-Zellen-vermittelten Immunität
US7709519B2 (en) * 2004-06-04 2010-05-04 Astellas Pharma Inc. Benzimidazolylidene propane-1,3 dione derivative or salt thereof
US20080171736A1 (en) * 2004-12-23 2008-07-17 Gregory Christopher W Treatment of Alzheimer's Disease and Mild Cognitive impairment using GnRH-I analogs and one or more of acetylcholinesterase inhibitors and NMDA receptor antagonists
CN101087618A (zh) * 2004-12-23 2007-12-12 航行药物公司 醋酸亮丙瑞林和乙酰胆碱酯酶抑制剂或nmda受体抑制剂在阿尔茨海默氏病治疗中的应用
KR101046039B1 (ko) * 2005-03-31 2011-07-01 아스텔라스세이야쿠 가부시키가이샤 프로판-1,3-디온 유도체 또는 그의 염
JP5406030B2 (ja) 2006-10-21 2014-02-05 アボット ゲーエムベーハー ウント カンパニー カーゲー 複素環化合物およびそれらのグリコーゲンシンターゼキナーゼ３阻害薬としての使用
JP2010538994A (ja) * 2007-09-11 2010-12-16 モンドバイオテック ラボラトリーズ アクチエンゲゼルシャフト 例えば肺炎連鎖球菌感染症を治療するためのｂｆｇｆ１−２４および任意での（ａｒｇ８）バソプレシンの使用
EP2185180A1 (de) * 2007-09-11 2010-05-19 Mondobiotech Laboratories AG Big-gastrin i als therapeutikum
EP2095818A1 (de) * 2008-02-29 2009-09-02 AEterna Zentaris GmbH Verwendung von LHRH-Antagonisten in nicht-kastrierenden Dosen
WO2009145690A1 (en) * 2008-05-29 2009-12-03 Isr Immune System Regulation Ab Method and means for treating viral disease, in particular hiv/aids
EP2621914B1 (de) 2010-09-27 2016-12-28 Abbott GmbH & Co. KG Heterocyclische verbindungen und ihre verwendung als glycogensynthasekinase-3-inhibitoren
US9090592B2 (en) 2010-12-30 2015-07-28 AbbVie Deutschland GmbH & Co. KG Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors
EP3560555A1 (de) * 2018-04-26 2019-10-30 LifeArc Zusammensetzung zur behandlung einer oder mehrerer östrogenvermittelter krankheiten

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3135743A (en) 1960-06-29 1964-06-02 Sterling Drug Inc Steroido[2. 3-d]isoxazoles and preparation thereof
JP2000511532A (ja) 1996-05-20 2000-09-05 メルク エンド カンパニー インコーポレーテッド 性腺刺激ホルモン放出ホルモンのアンタゴニスト
DE19911771B4 (de) 1999-03-17 2006-03-30 Zentaris Gmbh LHRH-Antagonist, Verfahren zu seiner Herstellung und seiner Verwendung
AU767440B2 (en) 1999-05-14 2003-11-13 Neurocrine Biosciences, Inc. Imidazo- and pyrrolo(1,2-A)pyrimid-4-ones as gonadotropin-releasing hormone receptor antagonists
CA2309395A1 (en) 1999-06-04 2000-12-04 Richard Lloyd Bowen Methods for preventing and treating alzheimer's disease
CA2386942A1 (en) * 1999-10-15 2001-04-26 Neurocrine Biosciences, Inc. Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
EP1393747A4 (de) 2000-04-13 2004-03-03 Takeda Chemical Industries Ltd Mittel zur prävention/behandlung von alzheimer-krankheit
KR100748294B1 (ko) 2000-07-05 2007-08-09 아스텔라스세이야쿠 가부시키가이샤 프로판-1,3-디온 유도체

Also Published As

Publication number Publication date
MXPA03008666A (es) 2004-10-15
RU2319501C2 (ru) 2008-03-20
CN1575185A (zh) 2005-02-02
EP1392348A1 (de) 2004-03-03
AU2002310788B2 (en) 2007-04-05
NZ544417A (en) 2008-03-28
KR20040000446A (ko) 2004-01-03
DK1392348T3 (da) 2008-09-29
IL156777A0 (en) 2004-02-08
SK14512003A3 (sk) 2004-08-03
ZA200305326B (en) 2003-07-30
NO20034322D0 (no) 2003-09-26
CN1317030C (zh) 2007-05-23
ES2307760T3 (es) 2008-12-01
PT1392348E (pt) 2008-09-09
PL362319A1 (en) 2004-10-18
JP2004529207A (ja) 2004-09-24
EP1392348B1 (de) 2008-07-09
BR0209290A (pt) 2004-07-13
CZ20033167A3 (cs) 2004-08-18
UA80679C2 (en) 2007-10-25
US20020177556A1 (en) 2002-11-28
RU2003134949A (ru) 2005-02-10
BG108339A (bg) 2004-11-30
HUP0400067A2 (hu) 2004-04-28
HK1072000A1 (en) 2005-08-12
US7288517B2 (en) 2007-10-30
SI1392348T1 (sl) 2008-12-31
NO20034322L (no) 2003-09-26
CA2444876A1 (en) 2002-12-27
WO2002102401A1 (en) 2002-12-27
DE60227507D1 (de) 2008-08-21

Similar Documents

Publication Publication Date Title
HK1072000A1 (en) Treatment of alzheimer's diseases with intemediatedoses of lhrh antagonists
ATE355374T1 (de) Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen
EA200201247A1 (ru) Соединения для лечения болезни альцгеймера
NO2016007I1 (no) Susoktokog
NO20053855D0 (no) 1-fenylalkankarboksylsyrederivater til behandling av neurodegenerative sykdommer.
ATE348829T1 (de) Pharmazeutische zusammensetzungen zur behandlung von störungen des zns oder anderen erkrankungen
BR0210122A (pt) Composto ou um sal farmaceuticamente aceitável do mesmo, método para o tratamento ou prevenção de uma doença, uso do composto ou de seu sal, e, método para preparar o mesmo
EA200800880A1 (ru) Комбинация росиглитазона и донепезила, предназначенная для улучшения когнитивной функции
DE60033649D1 (de) Verbindungen und therapeutische methoden
DK1268522T3 (da) LH-RH-antagonister samt fremstilling deraf og anvendelse deraf som lægemidler
DE60117541D1 (de) Candesartan zur Behandlung von Migräne
ATE298573T1 (de) Triazinonverbindungen zur behandlung von durch den befall mit parasitischen protozoen bedingten krankheiten
MXPA03008406A (es) Nuevas composiciones de medicamentos sobre la base de agentes anticolinergicos y agentes antagonistas de endotelina.
DE60330233D1 (de) Arsentherapie zur behandlung von autoimmunerkrankungen
EA200200987A1 (ru) Лечение заболеваний, связанных с серотонинергической системой
ATE341323T1 (de) Verwendung von darifenacin zur behandlung des harndrangs
DE69634497D1 (de) Il-6 mutein
ATE337790T1 (de) Verwendung von cortisol-sequestriermitteln zur behandlung von hypercortisolaemie-verwandten erkrankungen
ATE480560T1 (de) Zusammensetzung zur behandlung von periodontalen erkrankungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1392348

Country of ref document: EP

REN Ceased due to non-payment of the annual fee